Target intelligence / Profile preview

PRICKLE2 divergent transcript (PRICKLE2-DT)

Target
PRICKLE2-DT
Molecular classification
Other, long non-coding RNA, divergent transcript
01

Overview

PRICKLE2 divergent transcript (PRICKLE2-DT) is an annotated long non-coding RNA gene located at the PRICKLE2 locus on chromosome 3. Unlike the protein-coding PRICKLE2 gene, PRICKLE2-DT is classified as a divergent transcript—a non-protein-coding RNA transcribed in the opposite direction from the PRICKLE2 gene. To date, there are no data supporting a therapeutic, receptor, transporter, or enzyme role, and there is no documented association with disease. Most scientific and therapeutic attention focuses on the PRICKLE2 protein, which has key functions in neuronal development and disease. PRICKLE2-DT does not encode a functional protein and is not considered a therapeutic target. Note: If your intention was to refer to the PRICKLE2 protein-coding gene, that is a distinct entity (see [2][3][4][6] for neurodevelopmental and neurodegenerative disease relevance). The "divergent transcript" (PRICKLE2-DT) is not a canonical therapeutic target and should not be considered as such. The validity of PRICKLE2-DT as a biological target is very limited; the information listed here addresses only the non-coding transcript, not the protein target. If structural information about the PRICKLE2 protein or its role as a target is required, please specify "PRICKLE2" (not PRICKLE2-DT).

Other names
PRICKLE2 divergent transcriptPRICKLE2-DT
02

Mechanism of action

None known

03

Biological functions

Unknown or not well-characterizedNo documented role for PRICKLE2-DT as a protein or functional target
04

Disease associations

None specifically attributed to PRICKLE2-DTDisease roles discussed in the literature refer to the PRICKLE2 protein-coding gene

Beyond the preview

Go deeper on PRICKLE2 divergent transcript (PRICKLE2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRICKLE2 divergent transcript (PRICKLE2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call